RELATIVE CONTRIBUTION OF HUMAN ERYTHROCYTE ALDEHYDE DEHYDROGENASE TO THE SYSTEMIC DETOXIFICATION OF THE OXAZAPHOSPHORINES

Citation
Pa. Dockham et al., RELATIVE CONTRIBUTION OF HUMAN ERYTHROCYTE ALDEHYDE DEHYDROGENASE TO THE SYSTEMIC DETOXIFICATION OF THE OXAZAPHOSPHORINES, Drug metabolism and disposition, 25(12), 1997, pp. 1436-1441
Citations number
34
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00909556
Volume
25
Issue
12
Year of publication
1997
Pages
1436 - 1441
Database
ISI
SICI code
0090-9556(1997)25:12<1436:RCOHEA>2.0.ZU;2-H
Abstract
Detoxification of cyclophosphamide is effected, in part, by hepatic cl ass 1 aldehyde dehydrogenase (ALDH-l)-catalyzed oxidation of aldophosp hamide, a pivotal aldehyde intermediate, to the nontoxic metabolite, c arboxyphosphamide, This enzyme is found in erythrocytes as well. Detox ification of aldophosphamide may also be effected by enzymes, viz, cer tain aldo-keto reductases, that catalyze the reduction of aldophospham ide to alcophosphamide. Such enzymes are also found in erythrocytes, N ot known at the onset of this investigation was whether the contributi on of erythrocyte ALDH-1 and/or aldo-keto reductases to the overall sy stemic detoxification of circulating aldophosphamide is significant. T hus, NAD-linked oxidation and NADPH-linked reduction of aldophosphamid e catalyzed by relevant erythrocyte enzymes were quantified. ALDH-1-ca talyzed oxidation of aldophosphamide (160 mu M) to carboxyphosphamide occurred at a mean (+/- SD) rate of 5.0 +/- 1.4 atmol/min/rbc (red blo od cell). Aldo-keto reductase-catalyzed reduction of aldophosphamide ( 160 mu M) to alcophosphamide occurred at a much slower rate, viz. 0.3 +/- 0.2 atmol/min/rbc. Thus, at a pharmacologically relevant concentra tion of aldophosphamide, vir. 1 mu M, estimated aggregate erythrocyte ALDH-1-catalyzed aldophosphamide oxidation, viz, 2.0 mu mol/min, was o nly about 3% of estimated aggregate hepatic enzyme-catalyzed aldophosp hamide oxidation, viz. 72 mu mol/min; however, this rate is greater th an the estimated flow-limited rate of aldophosphamide delivery to the liver by the blood, viz, 1.5 mu mol/min. These observations/considerat ions suggest an important in vivo role for erythrocyte ALDH-I in syste mic aldophosphamide detoxification, Erythrocyte ALDH-1-effected oxidat ion of other aldehydes to their corresponding acids, e.g. retinaldehyd e to retinoic acid, may also be of pharmacological and/or physiologica l significance since a wide variety of aldehydes are known to be subst rates for ALDH-1.